pubrio
Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development) logo

Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development)

Privately Held
microsize.com
製藥產業28 employeesFounded 1994🇺🇸 美國

Microsize is a prominent pharmaceutical contract development and manufacturing organization (CDMO) based in the US. The company specializes in micronization, particle size engineering, and pharmaceutical development, focusing on enhancing the solubility and bioavailability of Active Pharmaceutical Ingredients (APIs). With the largest micronization business in North America, Microsize operates over 100,000 square feet of FDA-inspected facilities near Philadelphia, which include R&D centers, analytical labs, and GMP manufacturing suites. Microsize offers a range of core services, including micronization and milling for particle size reduction, particle classification for precise size distribution, and analytical characterization to support quality control. The company is equipped to handle highly potent active pharmaceutical ingredients (HPAPIs) with advanced containment technologies. With nearly three decades of experience, Microsize has processed hundreds of small molecule APIs and pharmaceutical excipients, serving a diverse customer base from biotech startups to large pharmaceutical companies. The leadership team brings extensive expertise in drug development and manufacturing, making Microsize a reliable partner in the pharmaceutical industry.

成立年份
1994
員工
28
行業
製藥產業
公司類型
Privately Held
總部
🇺🇸20 Pacific Dr, Quakertown, Pennsylvania 18951, US (+1)
專長
製藥產業

擴張情報

全新 · Pubrio 獨家

我們正在追蹤 Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development) 的市場擴張

全球擴張

即時
階段
探索中投入中進入中營運中
值得了解

關於 Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development) 的常見問題

關於 Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development) 業務、市場及增長訊號的快速解答。

Microsize is a prominent pharmaceutical contract development and manufacturing organization (CDMO) based in the US. The company specializes in micronization, particle size engineering, and pharmaceutical development, focusing on enhancing the solubility and bioavailability of Active Pharmaceutical Ingredients (APIs). With the largest micronization business in North America, Microsize operates over 100,000 square feet of FDA-inspected facilities near Philadelphia, which include R&D centers, analytical labs, and GMP manufacturing suites. Microsize offers a range of core services, including micronization and milling for particle size reduction, particle classification for precise size distribution, and analytical characterization to support quality control. The company is equipped to handle highly potent active pharmaceutical ingredients (HPAPIs) with advanced containment technologies. With nearly three decades of experience, Microsize has processed hundreds of small molecule APIs and pharmaceutical excipients, serving a diverse customer base from biotech startups to large pharmaceutical companies. The leadership team brings extensive expertise in drug development and manufacturing, making Microsize a reliable partner in the pharmaceutical industry.

立即展開你的旅程

可以先用平台,也可以先聊聊

自行使用 Pubrio,或讓我們的團隊協助研究、挖掘潛在客戶,甚至串接資料。

Start Journey Image
pubrio

Pubrio 將 50+ 個在地來源的商業、人才與意圖數據全球化整合,讓 AI 與營收團隊掌握完整市場視野。

© 2026 Pubrio。版權所有。